PROLM20 Antibody

Shipped with Ice Packs
In Stock

Description

Contextual Analysis of Antibody Naming Conventions

Antibody nomenclature typically follows standardized guidelines (e.g., WHO’s INN system). Examples from current databases include:

Antibody NameTarget/ApplicationDeveloper/Status
Glofitamab CD20/CD3e (DLBCL therapy)Roche/Approved (2023)
Regdanvimab SARS-CoV-2 spike proteinCelltrion/Emergency use
Loncastuximab CD19 (DLBCL)ADC Therapeutics/Approved

None align with "PROLM20," further supporting its absence in existing registries.

Antibody Characterization and Validation Challenges

Recent studies highlight critical issues in antibody reproducibility and validation:

  • YCharOS findings: 50–75% of commercial antibodies for human proteins perform adequately in specific applications, but ~12 publications per target included data from failed antibodies .

  • KO cell line superiority: Knockout controls are essential for validating antibody specificity in Western blots and immunofluorescence .

Therapeutic Antibody Development Workflow

The CPRIT Therapeutic Monoclonal Antibody Core outlines key stages :

  1. Lead identification: High-throughput screening of B-cell libraries.

  2. Optimization: Humanization, affinity maturation.

  3. Production: Scalable expression (e.g., CHO cells).

If PROLM20 exists, it would likely follow this pathway, but no evidence of its progression was found.

Clinical Antibody-Guided Therapy Case Study

A representative example from nephrology research :

ParameterResult (n=65)
Immunologic remission94% at 36 mo
Partial remission rate92%
Cumulative cyclophosphamide dose11.1 g (ABG) vs. 18.9 g (standard)

This demonstrates the importance of antibody-guided dosing but does not reference PROLM20.

Recommendations for Further Inquiry

  • Database searches: Consult ClinicalTrials.gov, WHO INN, or proprietary registries (e.g., Antibody Society’s therapeutic list ).

  • Vendor outreach: Contact antibody suppliers (e.g., Thermo Fisher, Abcam) for unpublished data.

  • Collaborative networks: Engage with institutions like UF Health’s neurogenetics team or Neurimmune for proprietary pipelines.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PROLM20 antibody; Os07g0219300 antibody; LOC_Os07g11910 antibody; B1130E10.109 antibody; OSJNBa0031C24.133 antibody; Prolamin PPROL 14P antibody
Target Names
PROLM20
Uniprot No.

Target Background

Function
PROLM20 Antibody targets a seed storage protein. This protein serves as a vital source of nitrogen, carbon, and sulfur for the developing seedling.
Database Links
Protein Families
Prolamin family
Subcellular Location
Vacuole, aleurone grain.

Q&A

What is LM20 antibody and what epitope does it specifically recognize?

LM20 is a rat monoclonal antibody (IgM isotype) that specifically recognizes and binds to methyl esterified homogalacturonan, which is an α-1,4-linked domain of pectic polysaccharides found in plant cell walls. Importantly, LM20 does not bind to un-esterified homogalacturonan, making it highly specific for the esterified form. The antibody was developed in the laboratory of Paul Knox at the University of Leeds and recognizes this epitope across several plant species .

How does LM20 differ from other anti-homogalacturonan antibodies?

LM20 binds to a higher density esterified homogalacturonan epitope compared to other similar antibodies such as JIM7. This distinction is critical for researchers interested in studying different degrees of pectin methylesterification in plant tissues. While both recognize methyl-esterified homogalacturonan, their different binding preferences enable researchers to distinguish between variations in the esterification patterns of pectins .

What are the optimal storage conditions for maintaining LM20 antibody activity?

For short-term stability, LM20 antibody should be stored at 2-8°C. For long-term stability, storage below -10°C is recommended, with careful attention to avoiding freeze/thaw cycles which can compromise antibody function. The antibody remains stable for more than 4 years when stored at 4°C according to manufacturer specifications. The preparation is supplied as a liquid in serum-free cell culture supernatant containing 0.02% sodium azide as a preservative .

What are the validated applications for LM20 antibody in plant cell wall research?

LM20 has been specifically tested and validated for immunofluorescence microscopy (at a 1:10 dilution) and ELISA (also at a 1:10 dilution). These techniques allow researchers to visualize the spatial distribution of methyl-esterified homogalacturonan in plant tissues and quantify its abundance, respectively. Highly esterified citrus pectin serves as an effective positive control for these applications .

How can LM20 be incorporated into multi-epitope detection strategies?

When designing experiments for comprehensive characterization of plant cell walls, LM20 can be incorporated into multi-antibody labeling protocols. For immunofluorescence, researchers can employ sequential or simultaneous labeling approaches using antibodies with non-overlapping host species or isotypes to avoid cross-reactivity. This approach is similar to the rational antibody design methods described for other target epitopes, where multiple binding regions can be engineered to enhance specificity and affinity .

What are the recommended methodological approaches for using LM20 in quantitative studies?

For quantitative analysis of methyl-esterified homogalacturonan content using LM20:

  • ELISA: Prepare serial dilutions of your sample alongside a standard curve using highly esterified citrus pectin

  • Maintain consistent incubation times and temperatures across all samples

  • Include appropriate controls (positive: highly esterified citrus pectin; negative: un-esterified pectin)

  • For comparative studies, maintain identical experimental conditions across all samples

This approach parallels established protocols for other antibodies in which careful standardization enhances reproducibility .

How do sample preparation methods affect LM20 epitope accessibility in different plant tissues?

Sample preparation significantly impacts LM20 epitope detection due to the complex architecture of plant cell walls. Consider these methodological approaches for optimizing epitope accessibility:

  • Chemical pretreatments:

    • Sodium carbonate (pH 11.4) for removal of ester crosslinks

    • Dilute alkali for removal of hemicellulose

    • Pectate lyase for enzymatic removal of non-esterified homogalacturonan

  • Fixation protocols:

    • Aldehydes (particularly paraformaldehyde) may mask methylesterified epitopes

    • Alcohol-based fixatives often preserve methylesterification patterns better

These considerations draw on principles similar to those used in antibody-epitope interaction studies for other targets, where sample preparation directly impacts the conformational state of the target epitope .

What strategies can resolve contradictory data when LM20 labeling conflicts with biochemical methylesterification assays?

When facing discrepancies between immunolabeling and biochemical data:

  • Consider epitope masking: Other cell wall components may block LM20 access to its target, giving artificially low signal despite high methylesterification

  • Evaluate extraction efficiency: Biochemical assays may not extract all pectin fractions equally

  • Perform sequential extractions with:

    • Water (soluble pectins)

    • CDTA (calcium-bound pectins)

    • Na2CO3 (covalently bound pectins)

  • Compare LM20 labeling with other methods:

    • Ruthenium red staining

    • FT-IR spectroscopy

    • Complementary antibodies with different specificities

This methodological approach resembles troubleshooting strategies used in other antibody-based research where multiple orthogonal techniques help resolve conflicting data .

How can LM20 be used in conjunction with enzymes to analyze pectin structure?

Advanced structural analysis of pectins can be achieved through combined enzyme-antibody approaches:

Enzyme TreatmentTarget StructureExpected Effect on LM20 BindingResearch Application
Pectin methylesteraseMethyl estersDecreased LM20 bindingConfirms specificity for methylesterified epitopes
Endo-polygalacturonaseNon-esterified HG regionsMinimal direct effect on LM20 epitopesReveals masked epitopes by removing adjacent structures
RhamnogalacturonanaseRhamnogalacturonan IPotential increase in LM20 accessibilityDistinguishes HG from RG-I regions
α-L-arabinofuranosidaseArabinan side chainsMay increase LM20 accessibilityExamines side chain influence on backbone recognition

This approach mirrors strategies used in rational antibody design studies where accessibility of the target epitope is carefully mapped and manipulated .

How does LM20 compare with chemical methods for detecting methylesterified pectins?

When comparing immunological and chemical detection methods:

  • Advantages of LM20:

    • High specificity for methylesterified homogalacturonan

    • Enables in situ visualization

    • Compatible with multi-labeling approaches

    • No interference with tissue morphology when properly applied

  • Advantages of chemical methods:

    • Provide quantitative degree of methylesterification

    • Not affected by epitope masking

    • Enable bulk tissue analysis

  • Recommended complementary chemical approaches:

    • Ruthenium red staining (basic)

    • m-Hydroxydiphenyl assay (quantitative)

    • FT-IR spectroscopy (structural)

This comparative framework draws on principles used in antibody validation studies where multiple orthogonal methods help establish reliability .

What are the theoretical limitations of using antibodies like LM20 for studying dynamic changes in pectin methylesterification?

Understanding the limitations of antibody-based approaches is crucial:

  • Temporal resolution constraints:

    • Fixed-time sampling provides snapshots rather than continuous monitoring

    • Rapid enzymatic modifications may occur during sample preparation

  • Spatial resolution limitations:

    • Antibody size (~150 kDa) may limit penetration in dense tissues

    • Resolution typically limited to light microscopy (~200 nm)

  • Methodological workarounds:

    • Time-course experiments with rapid fixation

    • Cryofixation to preserve transient states

    • Super-resolution microscopy techniques

    • Correlative light and electron microscopy

These limitations parallel challenges encountered in antibody-based research across various fields, where the physical properties of antibodies influence experimental design .

How might rational antibody design approaches improve anti-homogalacturonan antibodies like LM20?

Future improvements could leverage rational design methods similar to those described for other antibody targets:

  • Structure-guided modifications:

    • Complementary peptide grafting on CDR loops to enhance specificity

    • Antibody engineering to improve affinity while maintaining specificity

    • Development of single-domain variants with enhanced tissue penetration

  • Multi-epitope recognition:

    • Design of two-loop antibody variants to simultaneously recognize adjacent epitopes

    • Enhancement of binding affinity through cooperative binding interactions

Such approaches would follow principles demonstrated in rational antibody design studies where antibody complementarity-determining regions (CDRs) are engineered to optimize target interaction .

How can computational approaches enhance LM20-based experimental design and interpretation?

Advanced computational tools can significantly improve LM20-based research:

  • AI-backed platforms combined with structural biology data could:

    • Predict epitope accessibility in complex plant tissues

    • Model conformational changes during pectin modifications

    • Optimize antibody design for improved recognition

  • Machine learning algorithms can:

    • Identify patterns in immunolabeling distribution

    • Correlate labeling patterns with developmental or environmental factors

    • Predict effects of genetic modifications on pectin structure

These approaches leverage computational methods similar to those used in antibody redesign projects where machine learning enhances predictive capabilities .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.